OVERVIEW

Experts in lymphomas, plasma cell disorders, myeloproliferative neoplasms, acute myeloid leukemia, myelodysplastic syndrome, and coagulation disorders will provide exciting updates from ASH 2023 with a focus on the latest treatment advances relevant to your clinical practice. The day will include presentations, case reviews, and interactive question and answer sessions. This year, attendance is HYBRID: in-person AND on Zoom. 

For more information please visit the official event page.